Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and ty...Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22<sup>nd</sup> August and 30<sup>th</sup> September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only;88 received OGLDs + insulin;27 received insulin only. Metformin + sulfonylureas (128/187;68.45%) and premix only (76/115;66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin;six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years;duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.展开更多
文摘Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22<sup>nd</sup> August and 30<sup>th</sup> September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only;88 received OGLDs + insulin;27 received insulin only. Metformin + sulfonylureas (128/187;68.45%) and premix only (76/115;66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin;six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years;duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.
